The Health Technologies Fund (HTF) is a program of the Government of Ontario, developed by the Office of the Chief Health Innovation Strategist (OCHIS), administered by the Ontario Centres of Excellence. It supports the development of made-in-Ontario health technologies. It provides grants to businesses and research organizations seeking to improve the quality and deliverability of healthcare in the province by testing and adopting new technologies.(Source: www.oce-ontario.org)
The HTF is currently available to healthcare providers, technology developers, and academic institutions in the province of Ontario.
Created by the Ontario local government, the HTF is developed by the Office of the Chief Health Innovation Strategist and administered by the Ontario Centres of Excellence. Its main objective is to forge partnerships among publicly funded health service providers (HSPs), patients, academia and industry in streamlining the evaluation, procurement, and adoption of healthcare technologies in the Ontario health system. With the theme of “Better Care Closer to Home,” the HTF is primarily focused on improving the deliverability of healthcare services to patients in the province.
Key Areas of Focus
The HTF has two main drives:
- Pre-Market Evaluation:
Projects under this area deal with the implementation of validated technology in a healthcare setting through proper evaluation and assessment practices, and acquisition of evidence-based data on the cost-effectiveness of the technology as well as its perceived impact to the healthcare industry. This is to support procurement programs and support wide-scale procurement activities and programs in the future.
Projects under the pre-market evaluation stream may include identification of changes in the clinical workflow, collection of data & generating evidence to support procurement goals, and creating plans for adopting a validated technology.
Clinical trials that determine a technology’s efficacy are excluded as well as activities that are not based in the province of Ontario.
- Early Adoption:
Projects under this area support validated market-ready technologies that have been successfully implemented in one or more healthcare settings. These projects must involve a HIT collaborating to perform an additional implementation (and preferably multiple implementations) of the technology (in one or more healthcare settings) in order to evaluate the technology across multiple implementations, to generate further evidence to support value-based procurement and wide-scale adoption plan.
Projects under the early adoption stream may include streamlining and identifying changes in clinical workflow, to successfully integrate the technology, knowledge translation and user training, collecting evidence for future procurement activities, and creating procurement and adoption plans for healthcare providers.
Similar to projects under the pre-market evaluation, clinical trials that determine a technology’s efficacy and activities that are not based in the province of Ontario are excluded from the program.
Projects under both categories must align with the theme of Better Care Closer to Home and the technologies must have obtained required regulatory approvals and received initial user feedback.
The HTF is currently accepting applications from Health Innovation Teams (HITs), which comprises the following members:
One or more Providers of publicly-funded Health Services Provider. Eligible health care system applicants include (but are not limited to) family health teams, community care providers, long-term care homes, and hospitals.
- Technology partner
This includes Ontario-based for-profit health technology businesses that provide solutions and conduct research innovations that are in line with the HTF’s main drive.
Partners may be of any size or stage (start-up, small- to medium-sized enterprise, and multinational enterprise) with a research and development, and/or manufacturing presence in Ontario.
- Third-Party Evaluation Provider
Ontario-based evaluation team with expertise in technology adoption and diffusion, design and implementation, and health economics. The evaluation component of the project should support the development of a plan to support wider-scale procurement and/or adoption of the technology in Ontario.
- Other contributors
It is strongly recommended that partners such as community-based associations and advocacy groups are included in addition to Local Health Integration Network (LHIN) to provide sector expertise to ensure project development and implementation meets sector and local needs.
Pre-Market Evaluation projects Up to 50 percent of the eligible project cash costs up to a maximum amount of $500,000 for a term of up to 24 months.
Early Adoption projects Up to 50 percent of the eligible project cash costs up to a maximum amount of $1,000,000 for a term of up to 24 months.
Actual costs directly attributable to and necessary for the completion of the project and are not wholly or partially for another purpose.
- One-time costs, directly attributable to implementation of the project;
- Retroactive Expenses: OCE will acknowledge expenses after the approval date.
- Founder’s Salary: For a Start-up company, the maximum allowable compensation of $5,000 per month
- Cost of utilization/depreciation of Capital items i.e. equipment, testing tools, and instruments used for the project.
- Interested HITs may submit their expressions of interest (EOI) until May 9, 2018.
- Invitation to Submit a Full Application: July 2018
- Full Application submission deadline: August 16, 2018
Interested applicants may submit their EOIs to the OCE. After a thorough assessment, the OCE and OCHIS will contact candidates for the program to submit a full application.
For assistance in preparing your submission and to position your application for approval contact EVAMAX Group to help you with the process.